Leveraging Old Hepatitis C Therapies.

N Engl J Med

From West Virginia University College of Law, Morgantown (S.S.T.), the Institute of Human Virology, University of Maryland School of Medicine, Baltimore (S.K.), and the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (T.J.M.).

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMp2409842DOI Listing

Publication Analysis

Top Keywords

leveraging hepatitis
4
hepatitis therapies
4
leveraging
1
therapies
1

Similar Publications

Leveraging Old Hepatitis C Therapies.

N Engl J Med

December 2024

From West Virginia University College of Law, Morgantown (S.S.T.), the Institute of Human Virology, University of Maryland School of Medicine, Baltimore (S.K.), and the Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City (T.J.M.).

View Article and Find Full Text PDF

High-Throughput Screening of DPPIV Inhibitors Antagonizing GLP-1 Degradation Using an Enzymatic Activated Fluorescent Probe.

Anal Chem

December 2024

First Affiliated Hospital, College of Integrative Medicine, College of Pharmacy, Dalian Medical University, Dalian 116044, China.

Dipeptidyl peptidase IV (DPPIV, EC 3.4.14.

View Article and Find Full Text PDF
Article Synopsis
  • The interaction between peptides and MHC molecules is crucial for understanding autoimmunity and improving cancer immunotherapies.
  • Recent advancements reveal that traditional sequence-based prediction methods have limitations, prompting the need for better approaches.
  • The new structure-based methods, utilizing geometric deep learning and self-supervised learning, show improved accuracy and efficiency in predicting MHC-bound peptides, even outperforming conventional methods with significantly less data.
View Article and Find Full Text PDF

Introduction: Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, with treatment outcomes closely tied to liver function. This study evaluates the prognostic utility of the albumin-bilirubin (ALBI) score compared to the traditional Child-Pugh (CP) grading, leveraging real-world evidence from a large-scale, multi-center database.

Methods: The Liver Cancer IN Korea (LINK) research network, a multi-center initiative, retrospectively collected electronic health records from three academic hospitals in South Korea, encompassing HCC patients diagnosed between 2015 and 2020.

View Article and Find Full Text PDF

Introduction And Objectives: Advanced fibrosis is a crucial stage in the progression of autoimmune hepatitis (AIH), where fibrosis can either regress or advance. This study aims to leverage machine learning (ML) models for the assessment of advanced liver fibrosis in AIH patients using routine clinical features.

Patients And Methods: A total of 233 patients diagnosed with AIH and underwent liver biopsy were included in the discovery cohort.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!